¥2,259.50
0.13%
Tokyo, Sep 18, 11:30 am JST. Closed.
ISIN
JP3256000005
Symbol
4151
Index

Kyowa Kirin Stock price

¥2,256.00
-308.00 12.01% 1M
-159.00 6.58% 6M
-271.00 10.72% YTD
-144.00 6.00% 1Y
-447.00 16.54% 3Y
-1,844.00 44.98% 5Y
+671.00 42.33% 10Y
+1,430.00 173.12% 20Y
Tokyo, Closing price Fri, Sep 18 2026
-6.50 0.29%
ISIN
JP3256000005
Symbol
4151
Index
Industry

Is Kyowa Kirin a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,134 stocks worldwide.

Key metrics

Basic
Market capitalization
¥1.2t
Enterprise Value
¥894.1b
Net debt
positive
Cash
¥266.1b
Shares outstanding
523.6m
Valuation (TTM | estimate)
P/E
14.6
P/S
2.2 | 2.2
EV/Sales
1.7 | 1.7
EV/FCF
14.1
P/B
1.3
Dividends
DPS
¥70.00
Yield 1Y | 5Y
3.1% | 2.2%
Growth 1Y | 5Y
12.9% | 8.8%
Payout 1Y | 3Y
48.4% | 44.9%
Increased
10 Years
Financials (TTM | estimate)
Revenue
¥529.8b | ¥535.2b
EBITDA
¥101.8b
EBIT
¥96.0b
Net Income
¥81.3b
Free Cash Flow
¥63.6b
Growth (TTM | estimate)
Revenue
7.4% | 7.7%
EBITDA
11.7%
EBIT
45.3%
Net Income
111.7%
Free Cash Flow
257.1%
Margin
Gross
75.0%
EBITDA
19.2%
EBIT
18.1%
Net
15.4%
Free Cash Flow
12.0%
Financial Health
Equity Ratio
80.6%
Return on Equity
7.5%
ROCE
10.1%
ROIC
11.1%
Debt/Equity
0.0
More
EPS
¥155.4
FCF per Share
¥121.5
Short interest
-
Employees
5k
Rev per Employee
¥96.3m

Kyowa Kirin Stock Analysis

Unlock Scores for Free

Analyst Opinions

18 Analysts have issued a Kyowa Kirin forecast:

2x Buy
11%
6x Hold
33%
10x Sell
56%

Analyst Opinions

18 Analysts have issued a Kyowa Kirin forecast:

Buy
11%
Hold
33%
Sell
56%

Financial data from Kyowa Kirin

Jun '26
+/-
%
529,801 529,801
7% 7%
100%
- Direct Costs 132,420 132,420
2% 2%
25%
397,381 397,381
11% 11%
75%
- Selling and Administrative Expenses 167,412 167,412
0% 0%
32%
- Research and Development Expense 95,005 95,005
11% 11%
18%
101,769 101,769
12% 12%
19%
- Depreciation and Amortization 5,781 5,781
77% 77%
1%
EBIT (Operating Income) EBIT 95,988 95,988
45% 45%
18%
Net Profit 81,338 81,338
112% 112%
15%

In millions JPY.

Don't miss a Thing! We will send you all news about Kyowa Kirin directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Kyowa Kirin Stock News

Positive
WSJ
18 days ago
The agreements provide for all state Medicaid programs to pay prices for prescription drugs that match the lowest prices paid by other developed nations, the White House said
Neutral
GlobeNewsWire
3 months ago
New online resource brings together practical information, community perspectives, and expert guidance tailored to people with XLH across ages and life stages New online resource brings together practical information, community perspectives, and expert guidance tailored to people with XLH across ages and life stages

Company Profile

Kyowa Kirin Co., Ltd. engages in the manufacture and sale of medical and pharmaceutical products. It operates through the Pharmaceuticals and Bio-Chemicals segments. The Pharmaceuticals segment deals with the research, development, production, and sale of in vitro diagnostic reagents and ethical drugs concerning renal anemia, leukemia, cancer, allergies, and hypertension. The Bio-Chemicals segment produces and sells medical and industrial raw materials such as amino acids, nucleic acid-related compounds, and healthcare products. The company was founded by Benzaburo Kato on July 1, 1949 and is headquartered in Tokyo, Japan.

Head office Japan
CEO Dr. Miyamoto
Employees 5,161
Founded 1949
Website www.kyowakirin.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today